Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$209.01 - $232.56 $5,643 - $6,279
-27 Reduced 1.59%
1,675 $365,000
Q4 2023

Feb 09, 2024

SELL
$197.69 - $227.29 $31,432 - $36,139
-159 Reduced 8.54%
1,702 $386,000
Q3 2023

May 20, 2024

SELL
$201.05 - $221.7 $1,608 - $1,773
-8 Reduced 0.43%
1,861 $374,000
Q3 2023

Nov 13, 2023

SELL
$201.05 - $221.7 $1,608 - $1,773
-8 Reduced 0.43%
1,861 $374,000
Q2 2023

May 20, 2024

SELL
$211.93 - $241.33 $65,910 - $75,053
-311 Reduced 14.27%
1,869 $451,000
Q2 2023

Aug 04, 2023

SELL
$211.93 - $241.33 $65,910 - $75,053
-311 Reduced 14.27%
1,869 $451,000
Q1 2023

May 20, 2024

BUY
$213.32 - $257.83 $107,726 - $130,204
505 Added 30.15%
2,180 $500,000
Q1 2023

Apr 25, 2023

BUY
$213.32 - $257.83 $106,660 - $128,914
500 Added 29.76%
2,180 $500,000
Q4 2022

Feb 03, 2023

BUY
$203.72 - $248.97 $6,111 - $7,469
30 Added 1.82%
1,680 $395,000
Q3 2022

Nov 10, 2022

SELL
$204.81 - $262.19 $37,685 - $48,242
-184 Reduced 10.03%
1,650 $338,000
Q2 2022

Aug 01, 2022

SELL
$213.86 - $277.87 $9,837 - $12,782
-46 Reduced 2.45%
1,834 $430,000
Q1 2022

Apr 28, 2022

SELL
$259.82 - $298.18 $43,909 - $50,392
-169 Reduced 8.25%
1,880 $506,000
Q4 2021

Jan 20, 2022

BUY
$271.6 - $314.21 $10,864 - $12,568
40 Added 1.99%
2,049 $644,000
Q3 2021

Nov 02, 2021

BUY
$274.82 - $308.34 $129,440 - $145,228
471 Added 30.62%
2,009 $565,000
Q2 2021

Aug 06, 2021

BUY
$251.87 - $278.14 $12,089 - $13,350
48 Added 3.22%
1,538 $424,000
Q1 2021

Apr 23, 2021

BUY
$204.88 - $255.03 $128,459 - $159,903
627 Added 72.65%
1,490 $380,000
Q4 2020

Feb 02, 2021

SELL
$186.91 - $214.42 $61,867 - $70,973
-331 Reduced 27.72%
863 $176,000
Q3 2020

Oct 27, 2020

SELL
$167.03 - $201.3 $56,623 - $68,240
-339 Reduced 22.11%
1,194 $225,000
Q2 2020

Jul 16, 2020

BUY
$113.31 - $182.44 $49,629 - $79,908
438 Added 40.0%
1,533 $254,000
Q1 2020

Apr 27, 2020

SELL
$104.32 - $195.28 $6,989 - $13,083
-67 Reduced 5.77%
1,095 $138,000
Q4 2019

Jan 30, 2020

BUY
$163.48 - $173.61 $12,914 - $13,715
79 Added 7.29%
1,162 $197,000
Q3 2019

Nov 01, 2019

BUY
$159.77 - $178.1 $4,952 - $5,521
31 Added 2.95%
1,083 $182,000
Q2 2019

Aug 05, 2019

SELL
$144.16 - $172.9 $4,324 - $5,187
-30 Reduced 2.77%
1,052 $182,000
Q1 2019

May 01, 2019

SELL
$123.7 - $156.3 $5,195 - $6,564
-42 Reduced 3.74%
1,082 $166,000
Q4 2018

Feb 05, 2019

SELL
$120.82 - $174.09 $14,256 - $20,542
-118 Reduced 9.5%
1,124 $142,000
Q3 2018

Nov 01, 2018

SELL
$167.67 - $188.27 $13,413 - $15,061
-80 Reduced 6.05%
1,242 $216,000
Q2 2018

Jul 30, 2018

BUY
$160.33 - $189.41 $14,590 - $17,236
91 Added 7.39%
1,322 $237,000
Q3 2017

Nov 15, 2017

BUY
$149.47 - $160.56 $183,997 - $197,649
1,231 New
1,231 $184,000
Q3 2017

Nov 14, 2017

SELL
$149.47 - $160.56 $186,837 - $200,700
-1,250 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
1,250
1,250 $199,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.